Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas

Glioblastomas are the most common primary brain tumors in adults. These tumors exhibit a high degree of vascularization, and malignant progression from astrocytoma to glioblastoma is often accompanied by increased angiogenesis and the upregulation of vascular endothelial growth factor and its recept...

Full description

Saved in:

Bibliographic Details
Published in:	Cancer gene therapy Vol. 13; no. 4; pp. 385 - 392
Main Authors:	Kang, X, Xiao, X, Harata, M, Bai, Y, Nakazaki, Y, Soda, Y, Kurita, R, Tanaka, T, Komine, F, Izawa, K, Kunisaki, R, Setoyama, M, Nishimori, H, Natsume, A, Sunamura, M, Lozonshi, L, Saitoh, I, Tokino, T, Asano, S, Nakamura, Y, Tani, K
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01-04-2006
Subjects:	Adenoviridae - genetics Angiogenesis Angiogenesis inhibitors Angiogenic Proteins - biosynthesis Angiogenic Proteins - genetics Animals Antitumor activity Astrocytoma Brain cancer Brain Neoplasms - blood supply Brain Neoplasms - pathology Brain Neoplasms - therapy Brain tumors Care and treatment Cell Line, Tumor Dosage and administration Gene expression Gene therapy Genetic aspects Genetic Therapy Genetic Vectors Glioblastoma Glioblastoma - blood supply Glioblastoma - pathology Glioblastoma - therapy Glioblastoma cells Glioblastoma multiforme Health aspects Humans Inoculation Methods Mice Mice, SCID mRNA Neoplasm Transplantation Neovascularization, Pathologic - therapy RNA, Messenger - metabolism Transduction, Genetic Tumor cells Tumors Vascular endothelial growth factor Vascularization Japan
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Glioblastomas are the most common primary brain tumors in adults. These tumors exhibit a high degree of vascularization, and malignant progression from astrocytoma to glioblastoma is often accompanied by increased angiogenesis and the upregulation of vascular endothelial growth factor and its receptors. In this study, we investigated the in vivo antiangiogenic and antitumor effects of brain-specific angiogenesis inhibitor 1 (BAI1) using human glioblastoma cell lines. Glioblastoma cells were transduced with an adenoviral vector encoding BAI1 (AdBAI1), and Northern and Western blot analyses, respectively, demonstrated BAI1 mRNA and protein expression in the transduced tumor cells. Using an in vivo neovascularization assay, we found that angiogenesis surrounding AdBAI1-transduced glioblastoma cells transplanted into transparent skinfold chambers of SCID mice was significantly impaired compared to control treated cells. Additionally, in vivo inoculation with AdBAI1 of established subcutaneous or intracerebral transplanted tumors significantly impaired tumor growth and promoted increased mouse survival. Morphologically, the tumors exhibited signs of impaired angiogenesis, such as extensive necrosis and reduced intratumoral vascular density. Taken together, these data strongly indicate that BAI1 may be an excellent gene therapy candidate for the treatment of brain tumors, especially human glioblastomas.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0929-1903 1476-5500
DOI:	10.1038/sj.cgt.7700898